Skip to main content

Table 4 Suggested screening strategies based on cost-effectiveness analysis, stratified by age and BMI group

From: Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification

  Age group
30–44 45–59 60–74
BMI group Underweight 10-year 10-year 3-year
Normal 6-year 6-year 3-year
Overweight 4-year 3-year 3-year
Obese 3-year 3-year 3-year